Menu
Search
|

Menu

Close
X

Becton Dickinson and Co BDX.N (New York Stock Exchange)

253.83 USD
+1.98 (+0.79%)
As of 4:00 PM EDT
Previous Close 251.85
Open 250.99
Volume 122,994
3m Avg Volume 289,259
Today’s High 254.02
Today’s Low 250.99
52 Week High 265.87
52 Week Low 208.67
Shares Outstanding (mil) 269.06
Market Capitalization (mil) 67,763.61
Forward P/E 52.49
Dividend (Yield %) 0.77 ( 1.22 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.80 Mean rating from 20 analysts

KEY STATS

Revenue (mm, USD)
FY19
8,355
FY18
15,982
FY17
12,093
FY16
12,482
EPS (USD)
FY19
2.054
FY18
2.994
FY17
4.646
FY16
4.496
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
52.49
34.10
Price to Sales (TTM)
vs sector
3.98
7.99
Price to Book (MRQ)
vs sector
3.19
4.39
Price to Cash Flow (TTM)
vs sector
18.98
24.00
Total Debt to Equity (MRQ)
vs sector
96.73
17.94
LT Debt to Equity (MRQ)
vs sector
82.39
12.82
Return on Investment (TTM)
vs sector
3.06
12.64
Return on Equity (TTM)
vs sector
6.18
17.18

EXECUTIVE LEADERSHIP

Vincent Forlenza
Chairman of the Board, Chief Executive Officer, Since 2017
Salary: $1,191,250.00
Bonus: $1,980,000.00
Thomas Polen
President, Chief Operating Officer, Since 2018
Salary: $849,750.00
Bonus: $1,132,560.00
Christopher Reidy
Chief Financial Officer, Executive Vice President, Chief Administrative Officer, Since 2013
Salary: $818,200.00
Bonus: $902,785.00
Betty Larson
Executive Vice President- Human Resources, Chief Human Resources, Since 2018
Salary: --
Bonus: --
Samrat Khichi
Executive Vice President, General Counsel, Since 2017
Salary: $450,000.00
Bonus: $371,250.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1 Becton Dr
FRANKLIN LAKES   NJ   07417-1815

Phone: +1201.8476800
Site: www.bd.com/

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

SPONSORED STORIES